A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
Kibuuka H, Kimutai R, Maboko L, Sawe F, Schunk MS, Kroidl A, Shaffer D, Eller LA, Kibaya R, Eller MA, Schindler KB, Schuetz A, Millard M, Kroll J, Dally L, Hoelscher M, Bailer R, Cox JH, Marovich M, Birx DL, Graham BS, Michael NL, de Souza MS, Robb ML.
Kibuuka H, et al. Among authors: eller ma, eller la.
J Infect Dis. 2010 Feb 15;201(4):600-7. doi: 10.1086/650299.
J Infect Dis. 2010.
PMID: 20078213
Free PMC article.
Clinical Trial.